Sign in
FC

Fortive Corp (FTV)·Q3 2025 Earnings Summary

Executive Summary

  • Fortive delivered a clean Q3 2025 beat: revenue $1.03B (+2.3% reported, +1.9% core) and adjusted EPS $0.68, both above consensus; adjusted EBITDA rose 10% with margin expanding ~220 bps to 30.1% (consensus: Rev ~$1.007B*, EPS ~$0.57*).
  • Management raised FY25 adjusted EPS guidance to $2.63–$2.67 from $2.50–$2.60, citing Q3 outperformance and $1B of buybacks (21M shares, ~6% of diluted shares) executed in the quarter .
  • Segment performance was broadly positive: IOS grew 2.6% (core +2.2%) with adjusted EBITDA margin to 34.6%; AHS grew 1.9% (core +1.1%) with adjusted EBITDA margin to 28.1% .
  • Stock reaction catalysts: guidance raise, visible margin discipline with selective reinvestment, and accelerating recurring/software narrative (ServiceChannel AI release; strong radiation monitoring “Landauer”) alongside manageable tariff headwinds (~$0.01 EPS drag in Q3, minimal in Q4) .

What Went Well and What Went Wrong

What Went Well

  • Clear beat and margin expansion: Adjusted EPS $0.68 (+15.3% YoY) and adjusted EBITDA $309M (+10.4% YoY); margin expanded to 30.1% (+220 bps) on disciplined cost actions and operating leverage .
  • Capital allocation and guidance: Raised FY25 adjusted EPS to $2.63–$2.67 and executed $1B buybacks (21M shares, ~6% of diluted shares), positioning share count favorably .
  • Strategic narrative and innovation: “Fortive delivered solid results in our first quarter as a simpler, more focused company… ahead of our expectations across all key financial metrics” — CEO Olumide Soroye; highlights include ServiceChannel’s AI-powered release and Fluke’s solar ground fault locator, supporting recurring/software growth .

What Went Wrong

  • Tariff-related margin pressure: Adjusted gross margin was down ~60 bps YoY; direct tariff costs net of countermeasures were a ~$0.01 headwind to adjusted EPS in Q3 .
  • Europe softness: Western Europe deteriorated sequentially; management does not expect notable improvement through year-end .
  • Q3 gross margin within IOS declined ~90 bps (to ~65.7%) on tariffs; management plans reinvestment in Q4, and some Q3 benefits (capitalization/incentives) were one-time in nature .

Financial Results

Headline Results and Sequential Context

MetricQ2 2025Q3 2025Q4 2025 (Est)
Revenue ($USD Millions)$1,016 $1,027 $1,093*
Core Revenue Growth (%)(0.7)% +1.9% N/A
Adjusted EBITDA ($USD Millions)$288 $309 N/A
Adjusted EBITDA Margin (%)28.4% 30.1% N/A
GAAP Diluted EPS ($)$0.33 $0.35 N/A
Adjusted Diluted EPS ($)$0.58 $0.68 $0.8355*
GAAP Operating Cash Flow ($USD Millions)$205 $295 N/A
Free Cash Flow ($USD Millions)$180 $266 N/A

Note: Asterisked values are S&P Global consensus. Values retrieved from S&P Global.

Results vs. Wall Street Consensus (S&P Global)

MetricQ2 2025Q3 2025Q4 2025 (Est)
Revenue – Consensus ($USD Millions)$1,013*$1,007*$1,093*
Revenue – Actual ($USD Millions)$1,016 $1,027
EPS – Consensus ($)$0.5926*$0.5691*$0.8355*
EPS – Actual (Adjusted) ($)$0.58 $0.68
  • Q3: Revenue beat (~$1,027M vs ~$1,007M) and EPS beat ($0.68 vs ~$0.57).
  • Q2: Revenue slight beat; EPS slight miss ($0.58 vs ~$0.593*).
    Note: Asterisked values are S&P Global consensus. Values retrieved from S&P Global.

Segment Breakdown (Q3 2025 vs Q3 2024; Continuing Ops)

SegmentQ3 2024 Revenue ($M)Q3 2025 Revenue ($M)Reported/Core GrowthGAAP Operating Margin Q3 2024GAAP Operating Margin Q3 2025Adjusted EBITDA ($M) Q3 2024Adjusted EBITDA ($M) Q3 2025Adj. EBITDA Margin Q3 2024Adj. EBITDA Margin Q3 2025
Intelligent Operating Solutions (IOS)$681 $699 +2.6% / +2.2% 24.8% 25.9% $227 $242 33.3% 34.6%
Advanced Healthcare Solutions (AHS)$322 $328 +1.9% / +1.1% 11.4% 12.9% $87 $92 26.9% 28.1%

Additional margin color: IOS adjusted gross margin declined ~90 bps YoY to ~65.7% on tariffs; AHS adjusted gross margin ~58.4% was similar YoY .

KPIs and Cash

KPIQ3 2024Q3 2025
GAAP Operating Cash Flow ($USD Millions)$305 $295
Free Cash Flow ($USD Millions)$283 $266
TTM GAAP Operating Cash Flow ($USD Millions)$961 $1,019
TTM Free Cash Flow ($USD Millions)$874 $922
Share Repurchases (Quarter)$1,000M; 21M shares (~6% of diluted shares)
Average Diluted Shares (Q3) (Millions)352.3 333.4

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Adjusted Diluted EPSFY 2025$2.50–$2.60 $2.63–$2.67 Raised
Adjusted Effective Tax RateFY 2025N/AMid-teens Maintained (framework)
Adjusted Effective Tax RateQ4 2025N/ASingle digits due to discrete items New color
Tariffs Impact (net of countermeasures)Q4 2025N/ANot expected to be material Favorable
Core Revenue GrowthQ4 2025N/AModerate; AHS ~in line with Q3; IOS very modest Cautious
Net Interest ExpenseQ4 2025N/ASequential increase vs Q3 Higher
Capital AllocationFY 2025+Moratorium pre-spin Balance buybacks and small bolt-ons; framework doesn’t require M&A Strategic shift

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 2025)Previous Mentions (Q2 2025)Current Period (Q3 2025)Trend
AI/Technology initiativesNot highlighted in Q1 PR Not highlighted in Q2 PR ServiceChannel SaaS R2 adds AI-powered work order insights; innovation studio launched; Fluke solar GFL tool Increasing focus on AI-enabled software
Supply chain/logisticsN/AN/ATariff cost pressures offset partly by pricing and supply chain countermeasures Managing headwinds
Tariffs/MacroFY25 guidance included net impact of tariffs Demand uncertainty from trade policy; spin completed ~$0.01 EPS headwind in Q3; minimal expected in Q4 Stabilizing impact
Product performance (Fluke)N/AIOS resilient; flat revenue Return to growth; strong NA POS, improving channel inventory; focus on data center/defense Improving
Regional trendsN/AN/ANA strong; Western Europe weak; China mixed; India strong NA strength, EU softness persists
Regulatory/Healthcare policyN/AHealthcare reimbursement/funding changes impacting AHS Sequential improvement in AHS equipment/consumables demand; OBV Act context Stabilizing/sequentially better
R&D execution/CapexN/AN/ASome Q3 capitalization increased; selective reinvestment planned in Q4 Reinvesting growth oxygen
Recurring revenueN/AN/ARecurring growth outpaced consolidated; ambition to raise % materially (Fluke attach, HaaS templates) Structural mix shift to recurring

Management Commentary

  • “Fortive delivered solid results in our first quarter as a simpler, more focused company… ahead of our expectations across all key financial metrics… we executed $1 billion of share repurchases in the quarter.” — Olumide Soroye, CEO .
  • “Adjusted EBITDA was $309 million… margin expanded approximately 200 basis points to 30%… driven by operating leverage… and cost discipline.” — CFO commentary .
  • “We are raising our full year adjusted EPS guidance… reflecting adjusted EPS overperformance and the impact of buybacks.” — CFO .
  • “Our strategy to drive faster organic growth is built around innovation acceleration, commercial acceleration, and recurring customer value… ServiceChannel AI-powered release… Fluke GFL 1500 for solar.” — CEO .
  • “Share repurchases will be a big part of our capital allocation… focus on smaller bolt-on M&A; our value creation plan does not require M&A.” — Management .

Q&A Highlights

  • Margin trajectory and one-time items: Q3 benefited from increased software capitalization and incentive comp adjustments; OpEx to step up in Q4 as reinvestment resumes, while maintaining discipline .
  • Government shutdown exposure: Limited direct federal exposure; most government business is state/local; minimal impact on guidance .
  • Capital allocation: $1B buybacks driven by valuation and cash sources; future balanced approach with small bolt-ons, no transformational M&A .
  • Fluke demand signals: Return to growth, strong NA sell-through, improving channel inventory; focus on data centers, defense, India; increasing recurring attach .
  • AHS demand: Sequential improvement in capital equipment and consumables as reimbursement/funding visibility improved; software resilient .
  • Tax rate: Mid-teens through at least 2026; Q4 single-digit on discrete items .

Estimates Context

  • Q3 beat: Revenue $1,027M vs ~$1,007M*, adjusted EPS $0.68 vs ~$0.57* .
  • Q2 mixed: Revenue $1,016M vs ~$1,013M*, adjusted EPS $0.58 vs ~$0.593* .
  • Q4 preview: Consensus revenue ~$1,093M* and EPS ~$0.836*, with management calling for moderated core growth and higher net interest expense .
    Note: Asterisked values are S&P Global consensus. Values retrieved from S&P Global.

Key Takeaways for Investors

  • Quality beat with margin expansion and FY25 guidance raised: supports near-term multiple confidence; watch reinvestment pacing in Q4 .
  • Capital deployment is now a core lever: $1B buyback reduces share count; expect continued balance between repurchases and disciplined bolt-ons .
  • Recurring/software flywheel strengthening: ServiceChannel AI features, strong AHS software, and recurring attach at Fluke point to mix improving resilience .
  • Tariff headwinds manageable: ~$0.01 EPS drag in Q3; minimal in Q4; pricing and supply chain actions offset .
  • Regional setup: North America remains strong; Western Europe soft; India a growth bright spot; plan assumptions are conservative for EU .
  • Near-term trading: Guidance raise plus buybacks are positive catalysts; watch Q4 OpEx step-up and interest expense; consensus Q4 expectations appear reasonable with cautious core growth .
  • Medium-term thesis: Fortive Accelerated execution, cost discipline, and capital allocation shift underpin the 2026–2027 framework (3–4% organic growth, 50–100 bps margin expansion, high single-digit+ adjusted EPS growth) .